Have a personal or library account? Click to login
Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region Cover

Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region

Global Heart
Volume 20 (2025): Issue 1
By: Madeeha Khan,  Quratul Ain,  Jaka Sikonja,  Hijab Batool,  Muhammad Qasim Hayat,  Mohammad Iqbal Khan,  Urh Groselj and  Fouzia Sadiq  
Open Access
|Mar 2025

References

  1. 1Abifadel M, Boileau C. Genetic and molecular architecture of familial hypercholesterolemia. Journal of Internal Medicine. 2023;293(2):144–65. DOI: 10.1111/joim.13577
    Back to article
  2. 2Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–22. DOI: 10.1016/S0140-6736(20)30925-9
    Back to article
  3. 3Migliara G, Baccolini V, Rosso A, D’Andrea E, Massimi A, Villari P, et al. Familial hypercholesterolemia: A systematic review of guidelines on genetic testing and patient management. Frontiers in Public Health. 2017;5:252. DOI: 10.3389/fpubh.2017.00252
    Back to article
  4. 4Familial hypercholesterolaemia (FH): Report of a second WHO consultation, Geneva, 4 September 1998. World Health Organization; 1999. Available from: https://iris.who.int/handle/10665/66346
    Back to article
  5. 5Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease. European Heart Journal. 2013;34(45):3478–90. DOI: 10.1093/eurheartj/eht273
    Back to article
  6. 6Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: Meta-analyses of 11 million subjects. Journal of the American College of Cardiology. 2020;75(20):2553–66. DOI: 10.1016/j.jacc.2020.03.057
    Back to article
  7. 7Toft-Nielsen F, Emanuelsson F, Benn M. Familial hypercholesterolemia prevalence among ethnicities—Systematic review and meta-analysis. Frontiers in Genetics. 2022;13:840797. DOI: 10.3389/fgene.2022.840797
    Back to article
  8. 8Bucholz EM, Rodday AM, Kolor K, Khoury MJ, De Ferranti SD. Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999–2014). Circulation. 2018;137(21):2218–30. DOI: 10.1161/CIRCULATIONAHA.117.032321
    Back to article
  9. 9Raal FJ, Hovingh GK, Catapano AL. Familial hypercholesterolemia treatments: Guidelines and new therapies. Atherosclerosis. 2018;277:483–92. DOI: 10.1016/j.atherosclerosis.2018.06.859
    Back to article
  10. 10Sadiq F, Shafi S, Sikonja J, Khan M, Ain Q, Khan MI, et al. Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: A cross-sectional study. The Lancet Regional Health – Southeast Asia. 2023;100163. DOI: 10.1016/j.lansea.2023.100163
    Back to article
  11. 11Farhad A, Noorali AA, Tajuddin S, Khan SD, Ali M, Chunara R, et al. Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients. Progress in Cardiovascular Diseases. 2023;79:19–27. DOI: 10.1016/j.pcad.2023.07.007
    Back to article
  12. 12Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. American Journal of Cardiology. 1993;72(2):171–6. DOI: 10.1016/0002-9149(93)90155-6
    Back to article
  13. 13Matthias AT, Samaranayake TSP, Hewa PS. Screening for familial hypercholesterolemia in Sri Lanka: A laboratory-based multicenter study. International Journal of Noncommunicable Diseases. 2024;9(2):58–64. DOI: 10.4103/jncd.jncd_100_23
    Back to article
  14. 14Sharma SK, Adhikari S, Shah N, Aebischer Perone S, Lab B, Heller O, et al. Familial hypercholesterolemia in community-based KHDC Nepal program-baseline data. European Journal of Preventive Cardiology. 2022;29(Supplement 1):265. DOI: 10.1093/eurjpc/zwac056.184
    Back to article
  15. 15Barde AK, Sethi S, Bhargav M, Waghdhare S. Indian prevalence of familial hypercholesterolemia demystified by applying Dutch lipid clinic network criteria. International Journal of Advances in Medicine. 2022;9(12):1177–82. DOI: 10.18203/2349-3933.ijam20223018
    Back to article
  16. 16Chua YA, Razman AZ, Ramli AS, Mohd Kasim NA, Nawawi H. Familial hypercholesterolaemia in the Malaysian community: Prevalence, under-detection and under-treatment. Journal of Atherosclerosis and Thrombosis. 2021;28(10):1095–107. DOI: 10.5551/jat.57026
    Back to article
  17. 17Jeenduang N, Nuinoon M, Ratanawan C. Prevalence of familial hypercholesterolemia among the southern Thai population: A preliminary study; 2022. DOI: 10.21203/rs.3.rs-1046441/v1
    Back to article
  18. 18Jackson CL, Keeton JZ, Eason SJ, Ahmad ZA, Ayers CR, Gore MO, et al. Identifying familial hypercholesterolemia using a blood donor screening program with more than 1 million volunteer donors. JAMA Cardiolology. 2019;4(7):685–9. DOI: 10.1001/jamacardio.2019.1518
    Back to article
  19. 19De Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States national health and nutrition examination surveys (NHANES). Circulation. 2016;133(11):1067–72. DOI: 10.1161/CIRCULATIONAHA.115.018791
    Back to article
  20. 20Klevmoen M, Mulder JWCM, Roeters van Lennep JE, Holven KB. Sex differences in familial hypercholesterolemia. Curr Atheroscler Rep. 2023;25(11):861–868. DOI: 10.1007/s11883-023-01155-6
    Back to article
  21. 21Gupta R, Sharma M, Goyal NK, Bansal P, Lodha S, Sharma K. Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database. Indian Journal of Endocrinology and Metabolism. 2016;20(2):211–8. DOI: 10.4103/2230-8210.176362
    Back to article
  22. 22Roeters van Lennep JE, Tokgözolu LS, Badimon L, Dumanski SM, Gulati M, Hess CN, et al. Women, lipids, and atherosclerotic cardiovascular disease: A call to action from the European Atherosclerosis Society. European Heart Journal. 2023;44(39):4157–4173. DOI: 10.1093/eurheartj/ehad472
    Back to article
  23. 23Farooq M, Usman M. Pakistan needs an equitable investment in the health system and collaborative efforts. Lancet Global Health. 2023;11(2):e177–8. DOI: 10.1016/S2214-109X(22)00523-X
    Back to article
  24. 24Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: New insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. European Heart Journal. 2014;35(32):2146–57. DOI: 10.1093/eurheartj/ehu274
    Back to article
DOI: https://doi.org/10.5334/gh.1413 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Nov 7, 2024
Accepted on: Feb 24, 2025
Published on: Mar 10, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Familial hypercholesterolemia,
Prevalence,
Cardiovascular disease,
Pakistan,
South Asia,
Southeast Asia,
Screening

© 2025 Madeeha Khan, Quratul Ain, Jaka Sikonja, Hijab Batool, Muhammad Qasim Hayat, Mohammad Iqbal Khan, Urh Groselj, Fouzia Sadiq, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 20 (2025): Issue 1Next article